Location History:
- rue Ganzau, FR (2004)
- Strasbourg, FR (1990 - 2016)
Company Filing History:
4 out of 5,089 
1 out of 2 
1 out of 170 
Years Active: 1990-2016
Title: Jean De Barry: Innovator in Alzheimer's Disease Detection
Introduction
Jean De Barry is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of medical diagnostics, particularly in the detection of Alzheimer's disease. With a total of 4 patents, his work focuses on innovative methods and biomarkers that enhance the understanding and diagnosis of neurodegenerative diseases.
Latest Patents
Among his latest patents, one includes a biological complex specific for Alzheimer's disease detection in vitro. This invention comprises a complex of an Aβ amyloid peptide and a cell or a cellular membrane, serving as a biomarker for Alzheimer's disease (AD). Additionally, he has developed non-invasive methods for diagnosing Alzheimer's disease or monitoring its development using this biomarker. Another significant patent involves fluorescent boron-substituted dipyrromethenes, which are novel fluorescent compounds derived from non-fluorinated dipyrromethene-boron. This invention relates to the preparation of these compounds and their use for the fluorescent marking of biological molecules, particularly useful in medical diagnosis methods for neurodegenerative diseases.
Career Highlights
Jean De Barry has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Amoneta Diagnostics. His career reflects a commitment to advancing medical research and diagnostics, particularly in the realm of Alzheimer's disease.
Collaborations
Throughout his career, Jean has collaborated with notable colleagues, including Agnès Janoshazi and Corinne Mbebi-Liegeois. These collaborations have further enriched his research and contributions to the field.
Conclusion
Jean De Barry stands out as an influential inventor in the medical diagnostics field, particularly for Alzheimer's disease. His innovative patents and collaborations highlight his dedication to improving detection methods and understanding of neurodegenerative diseases.